Skip to main content

Advertisement

Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid

  • 83 Accesses

The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:436

Correction to: J Exp Clin Cancer Res (2019) 38:436

https://doi.org/10.1186/s13046-019-1438-y

In the original publication of this article [1], the images of Figs. 4 and 5 were exchanged and the legends of the two figures did not correspond due to a typesetting error.

Fig. 4
figure1

Effect of ATRA on the random motility of breast cancer cells. Biological triplicates of the indicated luminal (MDA-MB-361, MDA-MB-175VII and HCC-1419; marked in red) and basal (MDA-MB-157; marked in blue) cell lines. Cells were pre-treated with vehicle (DMSO) or ATRA. Each point is the Mean + SD of 40 cells. ***Significantly lower than the vehicle curve (p < 0.001 following two-way ANOVA Bonferroni post-test)

Fig. 5
figure2

ATRA effects on the levels of cardiolipins. a Biological triplicates of the indicated breast cancer cells were treated with vehicle (DMSO) or ATRA (10- 6 M) for 48 h. Left: The box plots show the median ± SD levels of cardiolipins (CLs). The number of different CL molecules identified by mass-spectrometry is indicated in parenthesis. Luminal cell-lines are marked in red and basal cell-lines are marked in blue. The luminal and basal cell-lines are ordered according to decreasing sensitivity to the anti-proliferative effect of ATRA from left to right, as indicated (decreasing ATRA-score). Right: The diagram indicates the correlations between the ATRA/DMSO ratio of the mean values calculated for CLs in each cell-line and the corresponding ATRA-score. b Biological triplicates of SK-BR-3 cells were treated with vehicle (DMSO) or ATRA (10- 6 M) for the indicated amounts of time. The box plot shows the median ± SD levels of cardiolipins (CLs). c Biological triplicates of SK-BR-3 cells were treated with vehicle (DMSO) or the indicated concentrations of ATRA for 48 h. The box plot shows the median ± SD levels of cardiolipins (CLs). *Significantly different (p < 0.05) from the corresponding vehicle treated control using the Student’s t-test. **Significantly different (p < 0.01) from the corresponding vehicle treated control using the Student’s t-test

The publisher sincerely apologizes for the inconvenience caused to the readers.

The original article has been corrected.

Reference

  1. 1.

    Terao M, et al. Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid. J Exp Clin Cancer Res. 2019;38:436.

Download references

Author information

Correspondence to Enrico Garattini.

Additional information

The original article can be found online at https://doi.org/10.1186/s13046-019-1438-y

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Terao, M., Goracci, L., Celestini, V. et al. Correction to: Role of mitochondria and cardiolipins in growth inhibition of breast cancer cells by retinoic acid. J Exp Clin Cancer Res 38, 496 (2019). https://doi.org/10.1186/s13046-019-1485-4

Download citation